Table 3 Incidence of hydatidiform mole (HM) reported in population-based studies since 1990.
From: Decreasing incidence of registered hydatidiform moles in Denmark 1999–2014
Author (year) | Population | Data source | N/R | Period | No | Incidence per 1000 total (complete HM/partial HM) | |||
|---|---|---|---|---|---|---|---|---|---|
Pregnancies | Viable conceptions* | Deliveries | Live births | ||||||
Scandinavia | |||||||||
Present study | Denmark | The Danish Pathology Registry | N | 1999–2014 | 1976 | 1.98 (0.9a/1.08) | |||
2007–2014 | 863 | 1.23 (0.61a/0.62) | 1.79 | ||||||
Olsen et al.37 | Denmark | The Danish National Patient Registry/The Danish Cancer Registry | N | 1977–1992 | 1520 | 1.1b | |||
Salehi et al.26 | Sweden | The Swedish Cancer Register/The Inpatient Register | N | 1973–2004 | 3844 | 1.2c | |||
Joneborg et al.5 | Stockholm County, Sweden | The Regional Cancer Register of Stockholm County/The Regional Pathology data base | R | 1991–2010 | 956 | 1.48d | 2.08e | ||
Flam et al.36 | Stockholm County, Sweden | The Regional Cancer Register of Stockholm County/medical records | R | 1975–1988 | 393 | 0.9f | 1.5 | ||
Loukovaara et al.4 | Finland | The hospital discharge registry of the National Research and Development Center for Welfare and Health | N | 1975–2001 | 1659 | 0.98 | |||
Europe | |||||||||
Savage et al.34 | England and Wales | Databases of the Trophoblastic Disease Centres at Charing Cross Hospital (London) and Weston Park Hospital (Sheffield) | N | 2000–2009 | 13,583 | 1.65g (0.70/0.95) | 2.13h | ||
Savage et al.27 | England and Wales | Databases of the Trophoblastic Disease Centres at Charing Cross Hospital (London) and Weston Park Hospital (Sheffield) | N | 1998–2007 | 14,161 | 1.69i | 2.17h | ||
Tham et al.33 | Northern England and North Wales | The Trophoblastic Screening and Treatment Centre, Weston Park Hospital (Sheffield) | R | 1991–1999 | 3637 | 1.38 | |||
Eysbouts et al.6 | The Netherlands | A national pathology database, PALGA | N | 1994–2013 | 5135 | 1.36 (0.52/0.67) | |||
Lybol et al.11 | The Netherlands | A national pathology database, PALGA | N | 1995–2008 | 3668 | 1.34 (0.47/0.69) | |||
Parazzini et al.25 | Lombardy, Northern Italy | Integrated Patients Database of the Lombardy Region | R | 1996–2008 | 1433 | 1.04j | |||
USA/Canada | |||||||||
Altman et al.8 | Nova Scotia, Canada | Nova Scotia Gestational Trophoblastic Disease Registry | N | 1990–2005 | 420 | 2.20k (0.71/1.45) | 2.64l (0.93/1.71) | 2.66 (0.94/1.72) | |
Smith et al.32 | New Mexico, USA | The New Mexico Tumor Registry | N | 1988–1997 | 389 | 1.20m (0.81/0.39) | 1.42 (0.96/0.46) | ||
Asia | |||||||||
Yuk et al.22 | South Korea | National Inpatient Sample, extracted records of 13% of patient per year | N | 2009–2015 | 285 | 1.10n (0.10/0.10) | |||
Kim et al.7 | Korea | Korea medical insurance system | N | 1991–1994 | 5855 | 2.05 | |||
Matsui et al.23 | Chiba Prefecture, Japan | Questionnaires registration system | R | 1985–2002 | 1876 | 1. 5o (0.83/0.67) | |||
Matsui et al.24 | Chiba Prefecture, Japan | Questionnaires registration system | R | 1974–2000 | 3778 | 2.27 | |||
